RedHill Biopharma (RDHL) Other Non Operating Income (2014 - 2019)

RedHill Biopharma (RDHL) has 6 years of Other Non Operating Income data on file, last reported at -$8000.0 in Q4 2019.

• Other Non Operating Income for Q4 2019 came in at -$8000.0, up 99.64% year-over-year; the trailing twelve-month figure through Dec 2019 was -$344000.0 (down 230.77% YoY), and the FY2019 annual result was -$344000.0, down 230.77% from the prior year.
• Other Non Operating Income fell to -$8000.0 in Q4 2019 per RDHL's latest filing, from -$5000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $1.7 million in Q3 2017 and troughed at -$3.9 million in Q4 2017.
• A 5-year average of -$507066.7 and a median of -$201000.0 in 2016 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2017 and 2019: Other Non Operating Income tumbled 527.86% in 2017, then jumped 2046.0% in 2019.
• A 5-year view of Other Non Operating Income shows it stood at -$248000.0 in 2015, then plunged by 312.1% to -$1.0 million in 2016, then slumped by 277.59% to -$3.9 million in 2017, then surged by 43.2% to -$2.2 million in 2018, then soared by 99.64% to -$8000.0 in 2019.
• Business Quant data shows RDHL's Other Non Operating Income at -$8000.0 in Q4 2019, -$5000.0 in Q3 2019, and -$1.3 million in Q2 2019.